BLS and NHIF signed the annex to R&D 2020-2022, however, the position of the professional organization remains unchanged

BLS and NHIF signed the annex to R&D 2020-2022, however, the position of the professional organization remains unchanged

The NHIF and BLS signed the annex to the R&D 2020-2022. This was made clear at a briefing after a joint meeting between the Board of Directors of the BMA and the National Assembly, convened at the initiative of the Minister of Health, Dr. Assen Medzhidiev.

The document regulates an increase in prices of clinical pathways in hospital care by 8%, and in medical diagnostic activity by 18%. It will enter into force on September 1 and will be sustainable for next year.

The annex also stated that after the adoption of a new budget and after the new prices for PIMP and SIMP were agreed, they would necessarily come into force with a back date from 01.01.2023.

"What we have done today is to successfully end the financial year. Most importantly, the medics will receive the money they are given, "said BLS Chairman Dr. Ivan Madjarov.

He added: "We all agreed today that there will be savings and it will be distributed according to the methodology we offer."

However, the chairman of the BMA stressed that the NHIF proposal for the next framework contract contained very unacceptable things for BMA.

"Despite the agreement reached, against the background of the proposals received by the NHIF for R&D 2023-2025, the position of the Medical Union regarding the negotiation process under the upcoming framework contract and the requested resignations remains unchanged," Dr. Madjarov concluded.




SatHealth
CME Academy
Medicalnews
Cluster

International partners

IAMRA
WMA- World Medical Association
FEMS European Federation of Salaried Doctors
CPME The Standing Committee of European Doctors
UEMS European Union of Medical Specialists